Triad Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Buy
730
+294
+67% +$141K 0.02% 363
2026
Q1
$214K Sell
436
-54
-11% -$29.3K 0.02% 458
2025
Q4
$284K Buy
+490
New +$277K 0.03% 396
2024
Q3
Sell
-78
Closed -$43.1K 828
2024
Q2
$43.1K Buy
+78
New +$44.7K 0.02% 251

Other funds holding TMO

Triad Wealth Partners's TMO Position: Q2 2026 in Review

Triad Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 67% in Q2 2026, buying an estimated $141K and bringing the position to 730 shares worth $419K. The position accounts for 0.02% of the portfolio, ranked #363.

Triad Wealth Partners first reported a position in TMO in Q2 2024 and has held it in 4 quarters since. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Triad Wealth Partners held 730 shares of Thermo Fisher Scientific worth $419K as of Q2 2026.
  • Triad Wealth Partners bought 294 Thermo Fisher Scientific shares in Q2 2026, an estimated $141K.
  • Thermo Fisher Scientific made up 0.02% of Triad Wealth Partners's portfolio in Q2 2026, its #363 holding.
  • Triad Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 4 quarters since.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.